Navigation Links
Combination Therapies Continue to Thrive Among Pharma Brands

A new study shows that combination therapies - combining two or more medications into one formulation - continue to be viable, affordable options for pharmaceutical brand teams to pursue and grow product franchise value.

Cutting Edge Information's report "Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies" reveals that 58% of companies that launch combination therapies increase revenues for their brands. The pharmaceutical industry shows no signs of slowing the trend to develop and promote combination drugs with new DTC advertisements for brands such as Vytorin and Caduet being broadcast.

"One reason the companies are pursuing combination therapies so heavily is that they are relatively cheap and a great solution to many generic woes," said Elio Evangelista, research team leader at Cutting Edge Information. Many companies can produce combination therapies for a fraction of the initial costs to develop the ingredient medications. Furthermore, combination drugs can often garner additional patent protection due to the nature of their new chemical makeup.

Research into combination therapies has met with both success and challenges. Pfizer backed off its initial plans to launch a combination of Lipitor with its new compound torcetrapib. However, as recently as March 2007, Roche had found success in combining a new investigational treatment for HIV with two existing treatments, Fuzeon and Prezista. According to a company statement, 98% of patients who received the investigational integrase inhibitor raltegravir, along with Fuzeon and the protease inhibitor Prezista, achieved undetectable levels of HIV according to new interim clinical data.

"Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies" examines combination therapies, along with six other lifecycle management strategies, to understand the mo tivating factors driving relaunch decisions. Furthermore, Cutting Edge Information collected key benchmarks on the strategies' average implementation costs, average return on investment, effectiveness and timing.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: